<DOC>
	<DOCNO>NCT01322633</DOCNO>
	<brief_summary>The primary objective ass whether risk gastric cancer increase pantoprazole user compare user proton pump inhibitor .</brief_summary>
	<brief_title>Risk Cancer Among Pantoprazole Users</brief_title>
	<detailed_description>All subject meet inclusion criterion include study .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Patients use pantoprazole proton pump inhibitor , enrollment health maintenance organization least 6 month , age 18 year old . Use proton pump inhibitor study entry , cancer diagnosis record medical history , diagnosis ZollingerEllison Syndrome medical history .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Pantoprazole</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>digestive system cancer</keyword>
	<keyword>cancer</keyword>
</DOC>